Floatz logo

Amantadine

Delirium

Methodist Rehabilitation CenterSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Delirium cohort.

Asset / SponsorPhaseRating
PROPOFOL
RenJi Hospital
Phase 4BB
ISOFLURANE
Duke University
Phase 4BB
Pyridostigmine
Konkuk University Medical Center
Phase 4BB
Clonidine
Insel Gruppe AG, University Hospital Bern
Phase 4BB
Cyclopofol
RenJi Hospital
Phase 4BB

View all 23 →

Same molecule, other indications

Amantadine is also rated in:

drug-induced dyskinesiaDormant
BBB
Indicative ·
72 / 100
View asset →
Parkinson diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
traumatic brain injuryDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →